Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Georgios Bakalos
Observed names:
Bakalos, Georgios,
G. Bakalos,
George Bakalos
Institutions:
University of Thessaly,
Helsinn (Switzerland)
Observed institutions:
F. Hoffmann-La Roche AG,
University of Thessaly,
Queen Mary University of London,
National and Kapodistrian University of Athens,
Helsinn (Switzerland)
ORCID:
0000-0003-1862-632X
Observed ORCID:
0000-0003-1862-632X
OpenAlex ID:
A5068763748
Advanced life support versus basic life support in the pre-hospital setting: A meta-analysis
2011
·
G. Bakalos
, M. Mamali
, et al.
·
Resuscitation
·
96
Drug Discontinuation in Studies Including a Switch From an Originator to a Biosimilar Monoclonal Antibody: A Systematic Literature Review
2018
·
Georgios Bakalos
, Elias Zintzaras
·
Clinical Therapeutics
·
46
PDF
A baseline tool for predicting response to peginterferon alfa‐2a in HB eAg‐positive patients with chronic hepatitis B
2018
·
H. L. Y. Chan
, D. Messinger
, et al.
·
Alimentary Pharmacology & Therapeutics
·
34
PDF
A network meta-analysis of randomized controlled trials for comparing the effectiveness and safety profile of treatments with marketing authorization for relapsing multiple sclerosis
2013
·
G. M. Hadjigeorgiou
, C. Doxani
, et al.
·
Journal of Clinical Pharmacy and Therapeutics
·
34
PDF
Comparative Immunogenicity Assessment of Biosimilars
2018
·
Thomas Schreitmüller
, Bettina Barton
, et al.
·
Future Oncology
·
33
PDF
On‐treatment prediction of sustained response to peginterferon alfa‐2a for HB eAg‐negative chronic hepatitis B patients
2014
·
Ioannis Goulis
, Stylianos Karatapanis
, et al.
·
Liver International
·
33
Monoclonal Antibody Biosimilars in Oncology: Critical Appraisal of Available Data on Switching
2018
·
Paul Declerck
, Georgios Bakalos
, et al.
·
Clinical Therapeutics
·
31
PDF
Evidence of Association Between Methylenetetrahydrofolate Reductase Gene and Susceptibility to Breast Cancer: A Candidate-Gene Association Study in a South-Eastern European Population
2011
·
Christos N. Papandreou
, Chrysa Doxani
, et al.
·
DNA and Cell Biology
·
27
Variants of the MTHFR gene and susceptibility to acute lymphoblastic leukemia in children: A synthesis of genetic association studies
2011
·
Elias Zintzaras
, Chrysoula Doxani
, et al.
·
Cancer Epidemiology
·
21
Final analysis of the international observational S-Collate study of peginterferon alfa-2a in patients with chronic hepatitis B
2020
·
Patrick Marcellin
, Qing Xie
, et al.
·
PLoS ONE
·
15
PDF
IL28B genotype is associated with cirrhosis or transition to cirrhosis in treatment-naive patients with chronic HCV genotype 1 infection: the international observational Gen-C study
2016
·
on behalf of the Gen-C study group
, Alessandra Mangia
, et al.
·
SpringerPlus
·
15
PDF
Impact of Safety-Related Dose Reductions or Discontinuations on Sustained Virologic Response in HCV-Infected Patients: Results from the GUARD-C Cohort
2016
·
Graham R. Foster
, Carmine Coppola
, et al.
·
PLoS ONE
·
15
Development pathways for subcutaneous formulations of biologics versus biosimilar development
2019
·
Artem Zharkov
, Bettina Barton
, et al.
·
Expert Review of Precision Medicine and Drug Development
·
10
Responses are durable for up to 5 years after completion of peginterferon alfa‐2a treatment in hepatitis B e antigen‐positive patients
2018
·
W.‐L. Chuang
, J. Jia
, et al.
·
Alimentary Pharmacology & Therapeutics
·
10
Assessing the relative effectiveness and tolerability of treatments in small cell lung cancer: A network meta-analysis
2013
·
Georgios Bakalos
, Michael Miligkos
, et al.
·
Cancer Epidemiology
·
8
A genotype-specific baseline score predicts post-treatment response to peginterferon alfa-2a in Hepatitis B e antigen-negative chronic hepatitis B
2018
·
Pietro Lampertico
, Diethelm Messinger
, et al.
·
Annals of Gastroenterology
·
7
PDF
An easy-to-use baseline scoring system to predict response to peginterferon alfa-2a in patients with chronic hepatitis B in resource-limited settings
2017
·
Pietro Lampertico
, Diethelm Messinger
, et al.
·
Antiviral Therapy
·
7
Extended treatment with pegylated interferon alfa/ribavirin in patients with genotype 2/3 chronic hepatitis C who do not achieve a rapid virological response: final analysis of the randomised N-CORE trial
2014
·
Mitchell L. Shiffman
, Hugo Cheinquer
, et al.
·
Hepatology International
·
7
A Predictive Model for Selecting Patients with HCV Genotype 3 Chronic Infection with a High Probability of Sustained Virological Response to Peginterferon Alfa-2a/Ribavirin
2016
·
Tarik Asselah
, Alex J. Thompson
, et al.
·
PLoS ONE
·
6
Simple Predictive Model for Identifying Patients with Chronic Hepatitis C and Hepatitis C Virus Genotype 4 Infection with a High Probability of Sustained Virologic Response with Peginterferon Alfa-2a/Ribavirin: Pooled Analysis of Data from Two Large, International Cohort Studies
2016
·
Tarik Asselah
, Gamal Esmat
, et al.
·
Advances in Therapy
·
4
Reply to ‘Biosimilars: a position paper of the European Society for Medical Oncology, with particular reference to oncology prescribers’
2017
·
Georgios Bakalos
, Thomas Schreitmüller
·
ESMO Open
·
3
Boceprevir Plus Peginterferon Alfa-2a/Ribavirin in Treatment-Naïve Hepatitis C Virus Genotype 1 Patients: International Phase IIIb/IV TriCo Trial
2016
·
Peter Ferenci
, Florin A. Caruntu
, et al.
·
Infectious Diseases and Therapy
·
3
PDF
A Genotype-Specific Baseline Score to Predict Response at 48 Weeks Post-Treatment to Peginterferon Alfa-2a in Patients with HBeAg-Negative Chronic Hepatitis B
2016
·
P. Lampertico
, D. Messinger
, et al.
·
Journal of Hepatology
·
3
Effectiveness of Peginterferon Alfa-2a Therapy in HBeAg-Positive and HBeAg-Negative Patients with Chronic Hepatitis B: Final Results 3 Years Post-Treatment of the Prospective, Global, Observational S-Collate Study
2016
·
P. Marcellin
, Q. Xie
, et al.
·
Journal of Hepatology
·
2
Quantifying the Return on Investment of Medical Affairs in the AI Era
2026
·
Georgios Bakalos
, Thomas Buechele
·
Research Square
·
1
PDF
Show more works
View as search
Works count:
39
Citation count:
473
H-index:
12
I10-index:
14
Year
Topic
Type